These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31450946)

  • 1. Reply to the Letter to the Editor Entitled "NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?".
    Turan Y; Demir V; Turan E; Hidayet Ş
    Angiology; 2020 Jan; 71(1):85-86. PubMed ID: 31450946
    [No Abstract]   [Full Text] [Related]  

  • 2. NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?
    Yilmaz Y; Eren F
    Angiology; 2020 Jan; 71(1):83-84. PubMed ID: 31288553
    [No Abstract]   [Full Text] [Related]  

  • 3. The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease.
    Turan Y
    Angiology; 2020 Jan; 71(1):77-82. PubMed ID: 31018673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to the Letter to the Editor Entitled: "The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases".
    Turan Y
    Angiology; 2020 Jan; 71(1):88. PubMed ID: 31597437
    [No Abstract]   [Full Text] [Related]  

  • 5. Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease.
    Lee SH; Yun SJ; Kim DH; Jo HH; Park YS
    J Clin Ultrasound; 2017 Sep; 45(7):391-399. PubMed ID: 28369989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography.
    Tapper EB; Sengupta N; Hunink MG; Afdhal NH; Lai M
    Am J Gastroenterol; 2015 Sep; 110(9):1298-304. PubMed ID: 26303130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.
    Simon TG; Corey KE; Cannon CP; Blazing M; Park JG; O'Donoghue ML; Chung RT; Giugliano RP
    Int J Cardiol; 2018 Nov; 270():245-252. PubMed ID: 29903515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply-Letter to the Editor: Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease.
    Kim M; Jun DW
    Clin Nutr; 2020 Jan; 39(1):306. PubMed ID: 31812470
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to the Letter to the Editor "Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease".
    Kutlu O; Altun Ö; Dikker O; Aktaş Ş; Özsoy N; Arman Y; Özgün Çil E; Özcan M; Aydın Yoldemir Ş; Akarsu M; Toprak İD; Kırna K; Kutlu Y; Toprak Z; Eruzun H; Tükek T
    Med Princ Pract; 2020; 29(1):98. PubMed ID: 31505512
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.
    Dogan S; Celikbilek M; Yilmaz YK; Sarikaya S; Zararsiz G; Serin HI; Borekci E; Akyol L; Pirti I; Davarci SE
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):298-304. PubMed ID: 25629574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply-Letter to the editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Jun DW; Lee S
    Clin Nutr; 2018 Jun; 37(3):1090. PubMed ID: 29478888
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply Letter to the Editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Lee SM; Jun DW
    Clin Nutr; 2018 Apr; 37(2):759. PubMed ID: 29366517
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.
    Petta S; Vanni E; Bugianesi E; Di Marco V; Cammà C; Cabibi D; Mezzabotta L; Craxì A
    Liver Int; 2015 May; 35(5):1566-73. PubMed ID: 24798049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver and the severity of acute pancreatitis.
    Mikolasevic I; Orlic L; Poropat G; Jakopcic I; Stimac D; Klanac A; Carovic F; Milic S
    Eur J Intern Med; 2017 Mar; 38():73-78. PubMed ID: 27825671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey.
    Hartleb M; Barański K; Zejda J; Chudek J; Więcek A
    Liver Int; 2017 Nov; 37(11):1706-1714. PubMed ID: 28489307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.
    Jaruvongvanich V; Wijarnpreecha K; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):629-634. PubMed ID: 28716600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use.
    Carrieri P; Duracinsky M; Marcellin F; Lazarus JV
    Hepatology; 2019 Jul; 70(1):443-444. PubMed ID: 30472796
    [No Abstract]   [Full Text] [Related]  

  • 20. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
    Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.